These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 32125256

  • 1. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.
    Teichgräber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, von Flotow P, Heilmeier B, Sixt S, Brucks S, Erbel C, Beschorner U, Werk M, Riambau V, Wienke A, Klumb CT, Thieme M.
    Radiology; 2020 May; 295(2):478-487. PubMed ID: 32125256
    [No Abstract] [Full Text] [Related]

  • 2. Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial.
    Teichgräber U, Lehmann T, Ingwersen M, Aschenbach R, Zeller T, Brechtel K, Blessing E, Lichtenberg M, von Flotow P, Heilmeier B, Sixt S, Brucks S, Erbel C, Beschorner U, Werk M, Riambau V, Wienke A, Klumb C, Thieme M, Scheinert D.
    Cardiovasc Intervent Radiol; 2022 Dec; 45(12):1774-1783. PubMed ID: 36088609
    [Abstract] [Full Text] [Related]

  • 3. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
    Schroeder H, Werner M, Meyer DR, Reimer P, Krüger K, Jaff MR, Brodmann M, ILLUMENATE EU RCT Investigators.
    Circulation; 2017 Jun 06; 135(23):2227-2236. PubMed ID: 28424223
    [Abstract] [Full Text] [Related]

  • 4. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun 06; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

  • 5. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
    Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky WB, Cardenas J, Werner M, Brodmann M, Mustapha JA, Mena-Hurtado C, Jaff MR, Holden AH, Lyden SP.
    Circulation; 2017 Sep 19; 136(12):1102-1113. PubMed ID: 28729250
    [Abstract] [Full Text] [Related]

  • 6. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D, RANGER SFA Investigators.
    JACC Cardiovasc Interv; 2018 May 28; 11(10):934-941. PubMed ID: 29730375
    [Abstract] [Full Text] [Related]

  • 7. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators.
    J Endovasc Ther; 2018 Feb 28; 25(1):109-117. PubMed ID: 29264999
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial.
    Teichgräber U, Lehmann T, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Blessing E, Lichtenberg M, Sixt S, Brucks S, Beschorner U, Klumb CT, Thieme M, Collaborators.
    EuroIntervention; 2020 Apr 03; 15(18):e1633-e1640. PubMed ID: 31687933
    [Abstract] [Full Text] [Related]

  • 9. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D, RANGER SFA Investigators.
    J Endovasc Ther; 2017 Aug 03; 24(4):459-467. PubMed ID: 28558502
    [Abstract] [Full Text] [Related]

  • 10. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
    Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G.
    Circ Cardiovasc Interv; 2019 Jun 03; 12(6):e007702. PubMed ID: 31195825
    [Abstract] [Full Text] [Related]

  • 11. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E.
    J Vasc Surg; 2019 Sep 03; 70(3):981-995.e10. PubMed ID: 31126769
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
    Tepe G, Schroeder H, Albrecht T, Reimer P, Diehm N, Baeriswyl JL, Brechtel K, Speck U, Zeller T.
    J Endovasc Ther; 2020 Apr 03; 27(2):276-286. PubMed ID: 32096451
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
    Teichgräber U, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Thieme M, Blessing E, Treitl M, Lichtenberg M, von Flotow P, Vogel B, Werk M, Riambau V, Wienke A, Lehmann T, Sixt S.
    Trials; 2016 Oct 28; 17(1):528. PubMed ID: 27793175
    [Abstract] [Full Text] [Related]

  • 14. Matched comparison of uncoated and paclitaxel-coated balloon angioplasty for isolated popliteal lesions excluding bail-out stenting.
    Böhme T, Noory E, Beschorner U, Bollenbacher R, Nührenberg T, Rastan A, Westermann D, Zeller T.
    Cardiovasc Revasc Med; 2024 Jun 28; 63():54-58. PubMed ID: 38245433
    [Abstract] [Full Text] [Related]

  • 15. Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.
    Laird JR, Schneider PA, Tepe G, Brodmann M, Zeller T, Metzger C, Krishnan P, Scheinert D, Micari A, Cohen DJ, Wang H, Hasenbank MS, Jaff MR, IN.PACT SFA Trial Investigators.
    J Am Coll Cardiol; 2015 Dec 01; 66(21):2329-2338. PubMed ID: 26476467
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F.
    JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1386-92. PubMed ID: 27388828
    [Abstract] [Full Text] [Related]

  • 17. Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial.
    Teichgräber U, Ingwersen M, Platzer S, Lehmann T, Zeller T, Aschenbach R, Scheinert D.
    Trials; 2021 Sep 28; 22(1):665. PubMed ID: 34583746
    [Abstract] [Full Text] [Related]

  • 18. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H, Meyer DR, Lux B, Ruecker F, Martorana M, Miller LE, Duda S.
    Eur J Vasc Endovasc Surg; 2017 Sep 28; 54(3):348-355. PubMed ID: 28778456
    [Abstract] [Full Text] [Related]

  • 19. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, Tepe G, Naisbitt S, Rosenfield K.
    JACC Cardiovasc Interv; 2014 Jan 28; 7(1):10-9. PubMed ID: 24456716
    [Abstract] [Full Text] [Related]

  • 20. Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions.
    Zeller T, Brechtel K, Meyer DR, Noory E, Beschorner U, Albrecht T.
    J Endovasc Ther; 2020 Oct 28; 27(5):683-690. PubMed ID: 32666871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.